Cargando…
Suppression of CCT3 inhibits malignant proliferation of human papillary thyroid carcinoma cell
Papillary thyroid carcinoma (PTC) is the most frequently occurring subtype of thyroid cancer. A certain portion of PTCs can progress to recurrent metastatic cancer. Currently, there remains no effective molecular target therapy for PTCs. As a subunit of the chaperonin containing TCP1 (CCT) complex,...
Autores principales: | Shi, Xiaohui, Cheng, Suisheng, Wang, Weixing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958781/ https://www.ncbi.nlm.nih.gov/pubmed/29805652 http://dx.doi.org/10.3892/ol.2018.8496 |
Ejemplares similares
-
Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells
por: Xu, Gang, et al.
Publicado: (2020) -
Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression
por: Liu, Wenlou, et al.
Publicado: (2022) -
Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK
por: Li, Weilong, et al.
Publicado: (2021) -
The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma
por: Wang, Nanpeng, et al.
Publicado: (2018) -
CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20
por: Li, Feng, et al.
Publicado: (2021)